Berkowitz Noah
Chief Medical Officer
Berkowitz Noah has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: May 13, 2026.
On the most recent filing, Berkowitz Noah is listed as Chief Medical Officer at ARVINAS, INC. Inside the rolling window, Berkowitz Noah reported no open-market purchases and 3 open-market sales totaling $249K in ARVN. The largest disclosed transaction in the window is a sale of 11,108 ARVN shares on May 11, 2026, worth $110K.
Companies traded
Other insiders at ARVN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$249K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Berkowitz Noah made?
Berkowitz Noah has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Berkowitz Noah trade?
Berkowitz Noah has filed SEC Form 4 disclosures for 1 company, including ARVN.
When was Berkowitz Noah's most recent SEC Form 4 filing?
Berkowitz Noah's most recent SEC Form 4 filing on Tracefour is dated May 13, 2026.
What is Berkowitz Noah's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Berkowitz Noah is listed as Chief Medical Officer.
What is Berkowitz Noah's total buy and sell value in the current window?
Inside the rolling retention window, Berkowitz Noah bought $0 and sold $249K based on SEC Form 4 filings.
What was Berkowitz Noah's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,108 ARVN shares on 2026-05-11, worth $110K, per SEC Form 4 filings.